# Brilinta DaYu Study

> **NCT01870921** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 2004 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT01870921
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-26
- **Primary completion:** 2015-09-30
- **Final completion:** 2015-09-30
- **Target enrollment:** 2004 (ACTUAL)
- **Last updated:** 2018-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01870921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01870921, "Brilinta DaYu Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01870921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*